AVITA Medical, Inc. (RCEL)
|52 Week Range||4.41-14.75|
|1y Target Est||-|
|DCF Unlevered||RCEL DCF ->|
|DCF Levered||RCEL LDCF ->|
|Debt / Equity||15.30%||Neutral|
Upgrades & Downgrades
Latest RCEL news
How Much Upside is Left in Avita Medical Inc. (RCEL)? Wall Street Analysts Think 27.42%
14 March 2023
The mean of analysts' price targets for Avita Medical Inc. (RCEL) points to a 27.4% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement amo...
AVITA Medical to Present at the TD Cowen 43rd Annual Health Care Conference
2 March 2023
VALENCIA, Calif. and MELBOURNE, Australia, March 02, 2023 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company leading the development and commercializatio...
Here's Why 'Trend' Investors Would Love Betting on Avita Medical Inc. (RCEL)
28 February 2023
Avita Medical Inc. (RCEL) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it t...
AVITA Medical, Inc. (RCEL) Q4 2022 Earnings Call Transcript
23 February 2023
AVITA Medical, Inc. (NASDAQ:RCEL ) Q4 2022 Earnings Conference Call February 23, 2023 4:30 PM ET Company Participants Caroline Corner - Managing Director, Investor Relations Jim Corbett - Chief Execut...
AVITA Medical to Announce Fourth Quarter and Full Year 2022 Financial Results and Provide 2023 Finan...
9 February 2023
VALENCIA, Calif. and MELBOURNE, Australia, Feb. 09, 2023 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company leading the development and commercialization...
Avita Medical Inc. (RCEL) Stock Jumps 6.2%: Will It Continue to Soar?
30 January 2023
Avita Medical Inc. (RCEL) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength d...
AVITA Medical: Experienced CEO Taking The Helm As Expansion Opportunities Await
23 January 2023
Shares have fallen by 83% over the past 3 years and are down 13% over the past year. Q3 "beat and raise" along with appointment of a highly experienced CEO could turn sentiment around here.
AVITA Medical Announces Management Changes and Fourth Quarter 2022 Earnings Conference Call
19 January 2023
VALENCIA, Calif. and MELBOURNE, Australia, Jan. 19, 2023 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH) (“AVITA Medical” or the “Company”), a regenerative medicine company leading th...
Avita: Micro-Cap With Big Time Approvals On Near Horizon
17 December 2022
Avita has a modest existing business selling its skin regeneration products. Its shares have dropped recently despite several successes with the FDA.
AVITA Medical® to Present at the Piper Sandler 34th Annual Healthcare Conference
21 November 2022
VALENCIA, Calif., and MELBOURNE, Australia, Nov. 21, 2022 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company leading the development and commercializatio...
AVITA Medical Inc. operates as a commercial-stage regenerative tissue company in the United States, Australia, and the United Kingdom. It offers regenerative products to address unmet medical needs in burn injuries, trauma injuries, chronic wounds, and dermatological and aesthetics indications, including vitiligo. The company's patented and proprietary platform technology provides treatment solutions derived from the regenerative properties of a patient's own skin. Its lead product is RECELL System, a device that enables healthcare professionals to produce a suspension of Spray-On Skin cells using a small sample of the patient's own skin for use in the treatment of acute thermal burns in patients eighteen years and older. The company has a research collaboration with the University of Colorado School of Medicine to establish pre-clinical proof-of-concept for a spray-on treatment of genetically corrected cells; and a research collaboration with Houston Methodist Research Institute to explore molecular reversal of cellular aging through a novel cell suspension delivery system. The company was formerly known as AVITA Therapeutics, Inc. and changed its name to AVITA Medical Inc. in December 2020. AVITA Medical Inc. was incorporated in 2000 and is based in Valencia, California.
Stock Value >
Financial Summary > Financial Statements > Financial Quarter Statements > Ratios Analysis > Dupont Analysis > Free Cash Flow > Operating Data > Balance Sheet Data >